Medifast Inc (MED):企業の財務・戦略的SWOT分析

◆英語タイトル:Medifast Inc (MED) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1699
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Retailing
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Medifast Inc (MED) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Medifast Inc (Medifast) manufactures, distributes, and commercializes weight management, weight-loss, and other consumable health and diet products. The company’s product portfolio includes a wide range of special diets, meal replacement products, and vitamins. It manufactures products at an FDA approved facility in Owings Mills, Maryland, the US; and sells them through various distribution channels including internet and retail stores in the US. Medifast offers products under Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, One Healthy Habit at a Time and Essential 1 brand names. The company has business presence in the US, Canada, Hong Kong, and Singapore. Medifast is headquartered in Baltimore, Maryland, the US.

Medifast Inc Key Recent Developments

Feb 26,2020 Medifast announces fourth quarter and full year 2019 financial results
Oct 07,2019 Medifast Names New Human Resources Executive Amid Historic Growth
Aug 01,2019 Medifast announces second quarter 2019 results
May 01,2019 Medifast announces first quarter 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Medifast Inc – Key Facts
Medifast Inc – Key Employees
Medifast Inc – Key Employee Biographies
Medifast Inc – Major Products and Services
Medifast Inc – History
Medifast Inc – Company Statement
Medifast Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Medifast Inc – Business Description
Medifast Inc – SWOT Analysis
SWOT Analysis – Overview
Medifast Inc – Strengths
Medifast Inc – Weaknesses
Medifast Inc – Opportunities
Medifast Inc – Threats
Medifast Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Feb 26, 2020: Medifast announces fourth quarter and full year 2019 financial results
Oct 07, 2019: Medifast Names New Human Resources Executive Amid Historic Growth
Aug 01, 2019: Medifast announces second quarter 2019 results
May 01, 2019: Medifast announces first quarter 2019 financial results
Feb 26, 2019: Medifast announces fourth quarter and full year 2018 financial results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Medifast Inc, Key Facts
Medifast Inc, Key Employees
Medifast Inc, Key Employee Biographies
Medifast Inc, Major Products and Services
Medifast Inc, History
Medifast Inc, Other Locations
Medifast Inc, Subsidiaries
Medifast Inc, Key Competitors
Medifast Inc, Ratios based on current share price
Medifast Inc, Annual Ratios
Medifast Inc, Annual Ratios (Cont...1)
Medifast Inc, Annual Ratios (Cont...2)
Medifast Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Medifast Inc, Performance Chart (2015 - 2019)
Medifast Inc, Ratio Charts

★海外企業調査レポート[Medifast Inc (MED):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SVB Financial Group:企業のM&A・事業提携・投資動向
    SVB Financial Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SVB Financial Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Polaris Infrastructure Inc (PIF):企業の財務・戦略的SWOT分析
    Summary Polaris Infrastructure Inc (Polaris Infrastructure), formerly Ram Power Corp is a renewable energy company that explores, acquires, operates and develops geothermal energy projects in Latin America. The company owns and operates San Jacinto Tizate Geothermal project, which is located in nort …
  • FLYHT Aerospace Solutions Ltd.:企業の戦略・SWOT・財務分析
    FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Smiths Group Plc (SMIN)-医療機器分野:企業M&A・提携分析
    Summary Smiths Group plc (Smiths Group) is a technology company. It offers products and services for threat and contraband detection, medical devices, energy, and communications industries through five business divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek …
  • ConocoPhillips:企業の戦略・SWOT・財務情報
    ConocoPhillips - Strategy, SWOT and Corporate Finance Report Summary ConocoPhillips - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Taihan Electric Wire Co Ltd (001440):企業の財務・戦略的SWOT分析
    Taihan Electric Wire Co Ltd (001440) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Dakota Valley Electric Cooperative:企業の戦略的SWOT分析
    Dakota Valley Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Anteo Diagnostics Ltd (ADO):企業の製品パイプライン分析2018
    Summary Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinica …
  • Titanium Metals Corporation:企業の戦略・SWOT・財務情報
    Titanium Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Titanium Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Washington University in St Louis-製薬・医療分野:企業M&A・提携分析
    Summary Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range o …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Vectren Corp (VVC):電力:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • Synexus Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • National Institute on Drug Abuse:製薬・医療:M&Aディール及び事業提携情報
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • IAV GmbH:企業の戦略的SWOT分析
    IAV GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Proactis Holdings Plc (PHD):企業の財務・戦略的SWOT分析
    Summary Proactis Holdings PLC (Proactis) is a technology company that develops and provides spend control and eprocurement solutions. The company offers solutions such as source-to-contract, purchase-to-pay, eCommerce and global framework. It provides source-to-contract solutions for supplier manage …
  • Moneygram International, Inc.:企業のM&A・事業提携・投資動向
    Moneygram International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moneygram International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Allightsykes Pty Ltd
    Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ChemoCentryx Inc (CCXI):製薬・医療:M&Aディール及び事業提携情報
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆